Showing 25 to 36 of 176 results
West Midlands Towns Report Highest Obesity Rates in UK
Three West Midlands towns—Walsall, Cannock Chase, and Tamworth—have the UK's highest obesity rates, with 36.2%, 37.8%, and 37.4% of residents, respectively, attributed to the cost of healthy food and easy access to fast food.
West Midlands Towns Report Highest Obesity Rates in UK
Three West Midlands towns—Walsall, Cannock Chase, and Tamworth—have the UK's highest obesity rates, with 36.2%, 37.8%, and 37.4% of residents, respectively, attributed to the cost of healthy food and easy access to fast food.
Progress
52% Bias Score
Excessive Sugar Consumption: Historical Roots, Health Impacts, and Potential Solutions
The widespread consumption of sugar, originating from Arab introduction in the 7th and 8th centuries, now contributes to significant health problems like obesity and diabetes in many countries, leading to various interventions such as sugar taxes and behavioral therapies.
Excessive Sugar Consumption: Historical Roots, Health Impacts, and Potential Solutions
The widespread consumption of sugar, originating from Arab introduction in the 7th and 8th centuries, now contributes to significant health problems like obesity and diabetes in many countries, leading to various interventions such as sugar taxes and behavioral therapies.
Progress
44% Bias Score
Weight-Loss Injections Show Promise in Extending Lifespans, Preventing Diseases
New weight-loss injections, GLP-1 agonists like Mounjaro and Wegovy, show promise in delaying age-related illnesses and reducing heart attack risk by half, based on a 17,000-patient trial, leading experts to suggest expanded access for up to half of Britons to improve health and longevity.
Weight-Loss Injections Show Promise in Extending Lifespans, Preventing Diseases
New weight-loss injections, GLP-1 agonists like Mounjaro and Wegovy, show promise in delaying age-related illnesses and reducing heart attack risk by half, based on a 17,000-patient trial, leading experts to suggest expanded access for up to half of Britons to improve health and longevity.
Progress
52% Bias Score
Weight-Loss Injections May Almost Halve Obesity-Related Cancer Risk
A study of 6,000 adults found that weight-loss injections, specifically GLP-1RAs, may reduce the risk of obesity-related cancers by almost 50%, a finding comparable to bariatric surgery; this discovery could lead to a new era of preventive cancer medicine.
Weight-Loss Injections May Almost Halve Obesity-Related Cancer Risk
A study of 6,000 adults found that weight-loss injections, specifically GLP-1RAs, may reduce the risk of obesity-related cancers by almost 50%, a finding comparable to bariatric surgery; this discovery could lead to a new era of preventive cancer medicine.
Progress
48% Bias Score
Diabetes Epidemic Devastates McAllen Family, Exposing City's Health Crisis
In McAllen, Texas, known as "America's fattest city," the Ceron family's tragic history with diabetes—three siblings died from the disease, others experienced amputations and blindness—exposes the city's alarmingly high diabetes rate (19.2% in Hidalgo County vs. 11.6% nationally), highlighting the u...
Diabetes Epidemic Devastates McAllen Family, Exposing City's Health Crisis
In McAllen, Texas, known as "America's fattest city," the Ceron family's tragic history with diabetes—three siblings died from the disease, others experienced amputations and blindness—exposes the city's alarmingly high diabetes rate (19.2% in Hidalgo County vs. 11.6% nationally), highlighting the u...
Progress
48% Bias Score
England's Obesity Crisis Deepens Despite Billions Spent
New data reveals a concerning rise in obesity rates in England, with 67.4% of adults now overweight or obese, despite billions spent on treatment and prevention; West Lindsey has the highest rate at 38.8%, and the crisis costs the NHS over £11 billion annually.
England's Obesity Crisis Deepens Despite Billions Spent
New data reveals a concerning rise in obesity rates in England, with 67.4% of adults now overweight or obese, despite billions spent on treatment and prevention; West Lindsey has the highest rate at 38.8%, and the crisis costs the NHS over £11 billion annually.
Progress
52% Bias Score
Fast Eating Linked to Digestive Problems, Type 2 Diabetes, and Weight Gain
Research indicates a link between fast eating and various health issues, including digestive problems, type 2 diabetes, and weight gain; studies suggest slowing down eating pace as a preventative measure.
Fast Eating Linked to Digestive Problems, Type 2 Diabetes, and Weight Gain
Research indicates a link between fast eating and various health issues, including digestive problems, type 2 diabetes, and weight gain; studies suggest slowing down eating pace as a preventative measure.
Progress
44% Bias Score
GLP-1 Receptor Agonists Show Comparable Effectiveness to Bariatric Surgery in Reducing Obesity-Related Cancer Risk
An Israeli study of 6,356 obese individuals with diabetes found that GLP-1 receptor agonists (GLP-1 RAs) and bariatric metabolic surgery showed similar low rates of obesity-related cancers, with GLP-1 RAs showing a 41% relative risk reduction compared to surgery; further research is needed to confir...
GLP-1 Receptor Agonists Show Comparable Effectiveness to Bariatric Surgery in Reducing Obesity-Related Cancer Risk
An Israeli study of 6,356 obese individuals with diabetes found that GLP-1 receptor agonists (GLP-1 RAs) and bariatric metabolic surgery showed similar low rates of obesity-related cancers, with GLP-1 RAs showing a 41% relative risk reduction compared to surgery; further research is needed to confir...
Progress
40% Bias Score
GLP-1 Weight-Loss Drugs May Reduce Obesity-Related Cancer Risk by 41%
A study of nearly 6,400 obese and diabetic individuals found that GLP-1 receptor agonists, while less effective for weight loss than bariatric surgery, may reduce obesity-related cancer risk by 41%, potentially through inflammation reduction; however, this observational study requires further invest...
GLP-1 Weight-Loss Drugs May Reduce Obesity-Related Cancer Risk by 41%
A study of nearly 6,400 obese and diabetic individuals found that GLP-1 receptor agonists, while less effective for weight loss than bariatric surgery, may reduce obesity-related cancer risk by 41%, potentially through inflammation reduction; however, this observational study requires further invest...
Progress
20% Bias Score
Weight Loss Injections' Rise Contributes to Weight Watchers' Bankruptcy
Simon, 34, lost 26 kg using Monjaro weight loss injections after years of failed dieting, including with Weight Watchers which has lost over a million members and filed for bankruptcy amid the rise of weight loss injections and social media.
Weight Loss Injections' Rise Contributes to Weight Watchers' Bankruptcy
Simon, 34, lost 26 kg using Monjaro weight loss injections after years of failed dieting, including with Weight Watchers which has lost over a million members and filed for bankruptcy amid the rise of weight loss injections and social media.
Progress
56% Bias Score
Weight Loss Injections Could Boost UK Economy by £4.5 Billion
Research presented at the European Congress on Obesity in Málaga estimates that providing semaglutide to eligible UK residents could boost the economy by £4.5 billion due to increased productivity among 2,660 trial participants who gained an average of 17 extra workdays annually, offsetting some of ...
Weight Loss Injections Could Boost UK Economy by £4.5 Billion
Research presented at the European Congress on Obesity in Málaga estimates that providing semaglutide to eligible UK residents could boost the economy by £4.5 billion due to increased productivity among 2,660 trial participants who gained an average of 17 extra workdays annually, offsetting some of ...
Progress
44% Bias Score
Weight Loss Injections: Pharmacy Access Planned
A potential multimillion-pound deal could allow pharmacies in England to offer weight loss injections like Ozempic and Wegovy for £9.90 after a short consultation, addressing current NHS limitations and long wait times.
Weight Loss Injections: Pharmacy Access Planned
A potential multimillion-pound deal could allow pharmacies in England to offer weight loss injections like Ozempic and Wegovy for £9.90 after a short consultation, addressing current NHS limitations and long wait times.
Progress
44% Bias Score
Showing 25 to 36 of 176 results